Prestige Consumer Healthcare Inc. (PBH) Comparison with companies in other sectors?

Prestige Consumer Healthcare Inc. has a share price of 49.23M. You can analyze Prestige Consumer Healthcare Inc. (PBH) competitors across different market sectors through stock heatmaps.

What are PBH's NET and operating margins?

Prestige Consumer Healthcare Inc. (PBH) operating margin is around 0.30, and net profit margin is approximately 0.19 as of the latest reports.

In what way does PBH's earnings per share (EPS) trend reflect its financial momentum?

Prestige Consumer Healthcare Inc. (PBH) EPS is 4.29 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Prestige Consumer Healthcare Inc. is 17.92, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Prestige Consumer Healthcare Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Prestige Consumer Healthcare Inc. like P/E which is 17.76, P/B which is 2.08, and PEG which is 38.19. Compare them with sector averages to evaluate if the stock is priced fairly.

Prestige Consumer Healthcare Inc.

PBH•NYSE

Healthcare

Medical - Distribution

$76.88

$0.60(0.79%)

Fundamental Analysis of Prestige Consumer Healthcare Inc. (PBH)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$4.29

P/E Ratio

17.92

ROE

0.12%

Net Margin

0.19%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$3.78B

Shares OutstandingTotal number of shares issued

$49.23M

Book Value/ShareNet worth per share

$36.92

Revenue/ShareAnnual revenue per share

$22.89

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$4.29

Net MarginNet income as percentage of revenue

18.86%

Operating MarginOperating income as percentage of revenue

29.60%

ROEReturn on shareholders' equity

12.20%

ROAReturn on total assets

6.31%

ROCEReturn on capital employed

10.22%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$4.90

Cash/ShareCash and equivalents per share

$1.97

FCF YieldFree cash flow as percentage of market cap

6.45%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for PBHFinancial Ratios Analysis details for PBH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for PBHSector Benchmarking details for PBH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Prestige Consumer Healthcare Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Prestige Consumer Healthcare Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Prestige Consumer Healthcare Inc.'s unique business strengths and challenges.

Key Financial Metrics for Prestige Consumer Healthcare Inc.

For Prestige Consumer Healthcare Inc., essential financial indicators include EPS 4.29, PE 17.92, and ROE 0.12. These key ratios reveal insights into Prestige Consumer Healthcare Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Prestige Consumer Healthcare Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Prestige Consumer Healthcare Inc.

Metrics like Net Margin 18.86% and ROA 6.31% shed light on how well Prestige Consumer Healthcare Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Prestige Consumer Healthcare Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Prestige Consumer Healthcare Inc.

Using ratios such as P/B Ratio 2.08 and PEG Ratio 38.19, investors can assess whether Prestige Consumer Healthcare Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Prestige Consumer Healthcare Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Prestige Consumer Healthcare Inc.

Financial health indicators, such as Debt/Equity Ratio 0.03 and Cash Flow $4.90, provide a snapshot of Prestige Consumer Healthcare Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Prestige Consumer Healthcare Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Prestige Consumer Healthcare Inc.

Investing in Prestige Consumer Healthcare Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Prestige Consumer Healthcare Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;